TipRanks
Gilead Sciences (CH:GILD)
:GILD

Compare Gilead Sciences (GILD) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Gilead Sciences
CHF118.78
CHF148.82B
-56.48
80.63%
17 Buy
4 Hold
0 Sell
Strong Buy
Bristol-Myers Squibb
$64.72
$121.73B
13.15
33.68%
8 Buy
12 Hold
1 Sell
Moderate Buy
Johnson & Johnson
$273.14
$613.99B
29.88
36.83%
14 Buy
4 Hold
0 Sell
Strong Buy
Merck & Company
$156.45
$350.19B
113.33
62.98%
14 Buy
7 Hold
0 Sell
Moderate Buy
Novartis
$159.98
$257.77B
21.87
8.92%
3 Buy
3 Hold
1 Sell
Moderate Buy
Pfizer
$28.57
$156.74B
37.00
6.59%
8 Buy
14 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:GILD
Gilead Sciences
122.60
56.55
85.62%
BMY
Bristol-Myers Squibb
59.70
16.92
39.56%
JNJ
Johnson & Johnson
258.45
71.58
38.31%
MRK
Merck & Company
142.79
57.79
67.98%
NVS
Novartis
143.28
14.74
11.46%
PFE
Pfizer
28.00
4.41
18.72%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts